This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...

Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...

The FDA has approved GSK’s gepotidacin (Blujepa) for treating uncomplicated urinary tract infections (uUTIs) in females aged ...

The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...

For the past six months, the city has been the battlefield for the two main factions of the Sinaloa drug cartel. (AP video: Martín Silva Rey). A student participates in an active shooter drill at the ...

In EAGLE-3, gepotidacin was statistically significantly superior to nitrofurantoin, with 58.5% of patients having therapeutic success (combined clinical and microbiological response) vs 43.6% of ...